Alva Weir Selected Research

Death Domain Receptors

8/2002

Modulation of the Fas signaling pathway by IFN-gamma in therapy of colon cancer: phase I trial and correlative studies of IFN-gamma, 5-fluorouracil, and leucovorin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alva Weir Research Topics

Disease

1	Fibrosis (Cirrhosis) 08/2022
1	HIV Infections (HIV Infection) 08/2022
1	Neoplasms (Cancer) 08/2022
1	Liver Diseases (Liver Disease) 08/2021
1	Liver Neoplasms (Liver Cancer) 08/2021
1	Hematoma 05/2021
1	Multiple Myeloma 01/2020
1	Neutropenia 01/2014
1	Hepatitis C 01/2014
1	End Stage Liver Disease 01/2013
1	Splenomegaly 01/2013
1	Infections 01/2013
1	Portal Hypertension 01/2013
1	Carcinoma (Carcinomatosis) 08/2002
1	Colonic Neoplasms (Colon Cancer) 08/2002

Drug/Important Bio-Agent (IBA)

2	Antiviral Agents (Antivirals)IBA 08/2021 - 01/2014
1	Fetal Proteins (Fetoprotein)IBA 08/2022
1	CI 966IBA 08/2021
1	Mitogen-Activated Protein KinasesIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2013
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2013
1	Fluorouracil (Carac)FDA LinkGeneric 08/2002
1	RNA (Ribonucleic Acid)IBA 08/2002
1	Death Domain ReceptorsIBA 08/2002
1	Leucovorin (Folinic Acid)FDA Link 08/2002

Therapy/Procedure

5	Therapeutics 08/2022 - 08/2002
1	Laparotomy 05/2021